ArticleJournal of the Chinese Medical Association : JCMA2026
Proposed study design for estimating COVID-19 vaccine effectiveness in post-pandemic Taiwan.
Article in Journal of the Chinese Medical Association : JCMA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-licensure observational studies are used to assess vaccine effectiveness (VE) when clinical randomized controlled trials are not feasible. Although vaccination engenders various effects at the individual and population levels, few studies have specifically examined the types of effects estimated in the VE study. The test-negative design (TND) is more commonly used to evaluate direct vaccine performance against the influenza virus, rotavirus, and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is preferably used within a standard sentinel surveillance platform, and certain constraints may affect its validity. After the World Health Organization declared that coronavirus disease 2019 (COVID-19) is no longer a public health emergency, developing robust methodologies for evaluating VE is critical. Accordingly, this study aims to (1) clarify the types of vaccine effects typically captured by current observational VE studies, and (2) propose a scientifically rigorous and operationally feasible study design for estimating seasonal COVID-19 VE against severe outcomes after the pandemic. After reviewing various VE methodological issues, including vaccine effect, study design, outcomes, and exposures of interest, key covariates, and Taiwan's post-pandemic context. We propose a refined population-based retrospective cohort design. This design enables estimating direct VE against severe COVID-19 outcomes in the post-pandemic era by utilizing Taiwan's integrated national databases and incorporating validated health-seeking behavior and healthcare access markers, evidence-based underlying conditions, and advanced statistical models. The proposed design provides a scientifically valid and feasible alternative to the TND for direct COVID-19 VE assessment in the absence of a sentinel surveillance platform. It is also applicable to other respiratory-pathogen-related vaccines, such as the seasonal influenza vaccine, and to countries with similar settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.